Newsroom

Sorted by: Latest

-

CRWV Investors Have Opportunity to Join CoreWeave, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--CRWV Investors Have Opportunity to Join CoreWeave, Inc. Fraud Investigation with the Schall Law Firm...
-

Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor

PETAH TIKVA, Israel & BOCA RATON, Fla.--(BUSINESS WIRE)--Biobeat closed a $50M Series B, led by Ally Bridge, OrbiMed, and Elevage, to expand U.S. commercialization of its 24 hour FDA-cleared ABPM....
-

Kara Wolke Recognized in the 2025 Lawdragon 500 Leading Plaintiff Financial Lawyers Guide

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray congratulates its partner Kara Wolke on being recognized in the 2025 Lawdragon 500 Leading Plaintiff Financial Lawyers Guide—a well-deserved acknowledgment of her outstanding work for investors....
-

BankUnited, Inc. to Announce Fourth Quarter and Fiscal Year 2025 Results

MIAMI LAKES, Fla.--(BUSINESS WIRE)--BankUnited, Inc. (NYSE: BKU) announced today that financial results for the quarter and fiscal year ended December 31, 2025, will be made public in a news release on Wednesday, January 21, 2026, prior to the market opening. A conference call to discuss quarterly results will be held at 9:00 a.m. ET that day with Chairman, President and Chief Executive Officer, Rajinder P. Singh, Chief Financial Officer, James G. Mackey, and Chief Operating Officer, Thomas M....
-

Equity Bancshares, Inc. Will Announce Fourth Quarter 2025 Results on January 21, 2026

WICHITA, Kan--(BUSINESS WIRE)--Equity Bancshares, Inc. (NYSE:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its fourth quarter financial results on Wednesday, January 21, 2026, with a press release issued after market close. Equity Chairman and Chief Executive Officer Brad Elliott and Chief Financial Officer Chris Navratil will hold a conference call and webcast to discuss earnings results on Thursday, January 22, 2026 at 10 a.m. eastern time or 9 a.m. central...
-

Emmaus Life Sciences Announces Strategic Transaction

TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that it has entered into a License and Exclusive Distribution Agreement with NeoImmuneTech, Inc. (KOSDAQ:950220), or NIT, pursuant to which Emmaus has granted NIT an exclusive license to all rights to market, sell and distribute Endari® (prescription grade L-glutamine oral powder) and any generic equivalents...
-

Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. O...
-

Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve...
-

Molina Healthcare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call Dates

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) today announced it will issue its earnings release for the fourth quarter and year ending December 31, 2025, after the market closes on Thursday, February 5, 2026, and will host a conference call and webcast to discuss the earnings release on Friday, February 6, 2026, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 0597929. A telephonic replay of...
-

BNY Mellon Municipal Bond Closed-End Funds Declare Distributions

NEW YORK--(BUSINESS WIRE)--BNY Mellon Investment Adviser, Inc. announced today that BNY Mellon Strategic Municipal Bond Fund, Inc. and BNY Mellon Strategic Municipals, Inc. (each, a "Fund") have declared a monthly distribution for each Fund's common shares as summarized below. The distributions are payable January 30, 2026 to shareholders of record on January 14, 2026, with an ex-dividend date of January 14, 2026.     Fund     Ticker Monthly Distribution Per Share Change from Prior Monthly Dist...